Jerome Bettis and Robin Miller are teaming up with Sanofi US to raise awareness of life-threatening allergic reactions (anaphylaxis) and spread the word that Auvi-Q™ (epinephrine injection, USP) is now available by prescription in pharmacies nationwide. Bettis, who is allergic to shellfish, and Miller, who is allergic to eggs, hope to help educate adults and caregivers of children at risk for severe allergic reactions.
Auvi-Q is the first-and-only epinephrine auto-injector with audio and visual cues for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. The size and shape of a credit card and the thickness of a smart phone, Auvi-Q is a breakthrough in epinephrine auto-injector design that talks patients and caregivers step-by-step through the injection process.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59439-auvi-q-epinephrine-injection-usp-now-available-by-prescription-in-u-s
Barclaycard US, the payments business of Barclays in the United States, today announced that it has partnered with FICO (NYSE: FICO), a leading predictive analytics and decision management software company, to offer complimentary FICO® Scores to its cardmembers. Barclaycard is the first top 10 issuer to provide FICO® Scores to its cardmembers, giving them unprecedented access to the same credit score used by banks and lenders at no additional cost.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64068-barclaycard-offers-complimentary-fico-scores-to-cardmembers
New research from Carfax shows that consumers are at considerable risk due to auto recalls being ignored. In fact, the number of cars for sale online with unfixed recalls increased an average of more than 25% in Iowa, Missouri, Kansas, Illinois, Indiana, Wisconsin and Michigan. Buyers in these neighboring Midwest states need to be concerned about this disturbing trend. Fortunately, finding open recalls and getting them fixed is easy.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60855-carfax-new-research-unfixed-recalled-cars-put-lives-at-risk
To coincide with the start of a new school year and Attendance Awareness Month, the Ad Council and U.S. Army are releasing a series of new public service advertisements (PSAs) addressing the importance of regular school attendance in middle school in order for students to stay on course to graduate high school. Created pro bono by Publicis Kaplan Thaler, the PSAs illustrate the fact that every absence, in any grade, excused or not, can negatively impact a child’s academic achievement and put their high school graduation at risk. To help parents keep track, two tools are being offered on the campaign website: a “Text2Track” mobile SMS program and a redesigned Attendance Calculator.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63028-ad-council-boost-attendance-absences-add-up
The USPSTF today issued a draft recommendation giving its second highest approval rating for CT screening for lung cancer for those at high risk, a move that if approved in final form, will trigger Medicare and insurance coverage and bring about a dramatic drop in the leading cause of cancer deaths.
Today, LCA also launched its Risk Navigator tool – www.AtRiskForLungCancer.org. Additionally, it expanded the hours of its support line – (800) 298-2436 – operating 8 a.m. to 7 p.m. EST. LCA will also launch a national educational advertising campaign in September to encourage the public to know their risk for lung cancer.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62719-lung-cancer-alliance-uspstf-recommends-ct-screening-for-lung-cancer
Asuragen Inc., a leading molecular diagnostics company, today announced results from a study demonstrating that a new molecular test called Xpansion Interpreter® can improve the determination of a woman’s risk of having a child with fragile X syndrome, the most common inherited cause of intellectual disability and autism, compared to existing risk measures. The Xpansion Interpreter Test is based on a technology breakthrough that reveals both the number and position of “interrupting” DNA sequences in the fragile X gene of the mother and more accurately estimates the likelihood that her child will have fragile X syndrome. The study will be published in the April issue of the American Journal of Medical Genetics and presented today at the 2013 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting in Phoenix, AZ.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60719-asuragen-xpansion-interpreter-xi-test-data-fragile-x-syndrome-autism
Takeda today announced the launch of a new expert Report on COPD, introduced at a Takeda organised press conference on the occasion of the 2012 European Respiratory Society (ERS) Annual Congress taking place from 1- 5 September in Vienna, Austria.
The Report, entitled ‘The Shifting Paradigm in Chronic Obstructive Pulmonary Disease (COPD) Management,’ was initiated and developed by Takeda Pharmaceuticals International GmbH and is a compilation of opinion articles from a panel of key international respiratory experts, the European Federation of Allergy and Airways Diseases Patients’ Association (EFA) and COPD patients, reflecting updated guidance and research. The new expert Report was developed in response to a recent shift in emphasis in COPD management which now places future risk at equal importance to treatment of current disability. Treatment objectives are now divided into two groups: reducing symptoms and reducing risk.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56582-expert-report-on-copd-launch
According to the results of a recent study conducted by researchers at the USDA-Agricultural Research Service Western Human Nutrition Research Center, the Northwest Cherry Growers are pleased to announce that consuming about 45 (280 g) sweet Bing cherries significantly decreased circulating concentrations of specific inflammatory biomarkers in the blood. According to Dr. Kent Erickson, Professor at UC Davis School of Medicine and a collaborator in the study, “Many studies by other investigators have demonstrated that some of those inflammation markers are associated with increased risk for some chronic diseases such as cardiovascular disease, diabetes, and cancer.” The findings of the study have been published in the March 2013 issue of The Journal of Nutrition.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61851-northwest-cherries-usda-study-health-benefits
Feeding America, the nation’s largest domestic hunger-relief organization, today released “Map the Meal Gap 2013,” which provides estimates of food insecurity at the county and congressional district level. Food insecurity is the U.S. Department of Agriculture’s measure of the lack of access to enough food for an active, healthy life for all household members.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62036-feeding-america-map-meal-gap-documents-americans-living-at-risk-of-hunger
During the third quarter, we were again able to capture the benefits of AEGON’s strategic priorities, resulting in solid earnings growth, improved profitability of sales, lower expenses and a continued strong capital position. Our franchise remains healthy, as evidenced by the particularly high level of At-Retirement and pension sales. At the same time, we are making essential investments to reshape our businesses in both our established and developing markets to respond effectively to the changing conditions and new realities. Although there are signs of gradually improving market conditions, there remains considerable uncertainty in the general economic environment. Consequently, we believe it is prudent and necessary to maintain a sufficient financial buffer while at the same time adhering to our strict risk and pricing discipline. The steps we are taking across our organization to get closer to our end customers, combined with the strength of our current position, give us full confidence in the prospects for our business going forward.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58637-aegon-quarter-3-results
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the initiation of its Phase III clinical program called Cdiffense to evaluate the safety, immunogenicity and efficacy of an investigational vaccine for the prevention of primary symptomatic Clostridium difficile infection (CDI). Clostridium difficile (C. diff) is a potentially life-threatening, spore-forming bacterium that causes intestinal disease. The risk of C. diff increases with age, antibiotic treatment and time spent in hospitals or nursing homes, where multiple cases can lead to outbreaks. The investigational vaccine is designed to help protect at-risk individuals from C. diff, which is emerging as a leading cause of life-threatening, healthcare-associated infections (HAIs) worldwide.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62652-sanofi-pasteur-initiates-phase-iii-study-of-investigational-vaccine
To text or not to text? As, Valentine’s Day approaches, that is the question for the Romeos and Juliets of today’s digital world. Cricket Wireless commissioned a national survey1 to determine how people are beginning and ending relationships via mobile phone and to uncover lethal communication behaviors. According to the survey, 30 percent of Americans would ask someone out via text. Wooers must learn the digital courting code or risk suffering a tragic ending.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/56773-cricket-wireless-relationship-communication-survey-for-valentine-s-day
